287 related articles for article (PubMed ID: 32991878)
21. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
22. Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.
Khamchun S; Sueksakit K; Chaiyarit S; Thongboonkerd V
J Biol Inorg Chem; 2019 Mar; 24(2):235-246. PubMed ID: 30701361
[TBL] [Abstract][Full Text] [Related]
23. Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress.
Qin B; Wang Q; Lu Y; Li C; Hu H; Zhang J; Wang Y; Zhu J; Zhu Y; Xun Y; Wang S
Oxid Med Cell Longev; 2018; 2018():1271864. PubMed ID: 29849862
[TBL] [Abstract][Full Text] [Related]
24. Proteome of human calcium kidney stones.
Canales BK; Anderson L; Higgins L; Ensrud-Bowlin K; Roberts KP; Wu B; Kim IW; Monga M
Urology; 2010 Oct; 76(4):1017.e13-20. PubMed ID: 20709378
[TBL] [Abstract][Full Text] [Related]
25. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
26. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
27. Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy.
Dong F; Jiang S; Tang C; Wang X; Ren X; Wei Q; Tian J; Hu W; Guo J; Fu X; Liu L; Patzak A; Persson PB; Gao F; Lai EY; Zhao L
Free Radic Biol Med; 2022 Feb; 179():288-300. PubMed ID: 34767921
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection.
Worcester E; Evan A; Bledsoe S; Lyon M; Chuang M; Orvieto M; Gerber G; Coe F
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1061-9. PubMed ID: 17028259
[TBL] [Abstract][Full Text] [Related]
29. Differential bound proteins and adhesive capabilities of calcium oxalate monohydrate crystals with various sizes.
Peerapen P; Thongboonkerd V
Int J Biol Macromol; 2020 Nov; 163():2210-2223. PubMed ID: 32956748
[TBL] [Abstract][Full Text] [Related]
30. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.
De Bellis R; Piacentini MP; Meli MA; Mattioli M; Menotta M; Mari M; Valentini L; Palomba L; Desideri D; Chiarantini L
PLoS One; 2019; 14(6):e0218734. PubMed ID: 31238335
[TBL] [Abstract][Full Text] [Related]
31. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
32. Effects of high-dose uric acid on cellular proteome, intracellular ATP, tissue repairing capability and calcium oxalate crystal-binding capability of renal tubular cells: Implications to hyperuricosuria-induced kidney stone disease.
Sutthimethakorn S; Thongboonkerd V
Chem Biol Interact; 2020 Nov; 331():109270. PubMed ID: 32991862
[TBL] [Abstract][Full Text] [Related]
33. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
34. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Asplin JR; Parks JH; Coe FL
Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
[TBL] [Abstract][Full Text] [Related]
35. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
Khan SR
Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
[TBL] [Abstract][Full Text] [Related]
36. Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.
Zhou J; Jin J; Li X; Zhao Z; Zhang L; Wang Q; Li J; Zhang Q; Xiang S
Urolithiasis; 2018 Jun; 46(3):231-241. PubMed ID: 28567512
[TBL] [Abstract][Full Text] [Related]
37. Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.
Cao Y; Liu W; Hui L; Zhao J; Yang X; Wang Y; Niu H
Urolithiasis; 2016 Oct; 44(5):389-97. PubMed ID: 27040948
[TBL] [Abstract][Full Text] [Related]
38. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury.
Ye QL; Wang DM; Wang X; Zhang ZQ; Tian QX; Feng SY; Zhang ZH; Yu DX; Ding DM; Xie DD
Chem Biol Interact; 2021 Sep; 347():109605. PubMed ID: 34333021
[TBL] [Abstract][Full Text] [Related]
39. Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.
Mulay SR; Eberhard JN; Desai J; Marschner JA; Kumar SV; Weidenbusch M; Grigorescu M; Lech M; Eltrich N; Müller L; Hans W; Hrabě de Angelis M; Vielhauer V; Hoppe B; Asplin J; Burzlaff N; Herrmann M; Evan A; Anders HJ
J Am Soc Nephrol; 2017 Mar; 28(3):761-768. PubMed ID: 27612997
[TBL] [Abstract][Full Text] [Related]
40. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
